Director/PDMR Shareholding
03 August 2010 - 4:00PM
UK Regulatory
TIDMGWP
RNS Number : 4006Q
GW Pharmaceuticals PLC
02 August 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 2 August 2010: GW Pharmaceuticals (AIM: GWP) hereby provides
notification that the Company has today been notified that Dr Geoffrey Guy, a
Director and Executive Chairman of the Company, has today exercised an option to
acquire 106,167 ordinary shares of 0.1p each, equating to 0.08% of the issued
ordinary share capital at an exercise price of 36.2 pence per share.
Dr Guy has further notified the Company that the exercise of options follows the
sale by Dr Guy of 4,910 ordinary shares of 0.1p each on 28th July 2010, at the
market price of 117.1 pence; 51,910 ordinary shares of 0.1p each on 29th July
2010 at the market price of 116 pence; 2,260 ordinary shares of 0.1p each on
30th July 2010 at the market price of 111.2 pence and the sale of 40,920
ordinary shares of 0.1p each today at the market price of 108.3 pence per share.
The total number of shares sold of 100,000 equates to 0.08% of the issued
ordinary share capital.
Following these notifications Dr Guy's beneficial interest has increased to
18,351,441 ordinary shares, amounting to 14.10% of the shares in issue.
The total number of shares outstanding in the Company is 130,187,159 ordinary
shares of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44
(0)1980 557 000
Adam George, Company Secretary
Piper Jaffray Ltd (Nominated Adviser)
Neil Mackison/Rupert Winckler +44 (0)
203 142 8700
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFITTAIFIII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles